5paisa Capital Limited has published a corrigendum to its newspaper advertisement regarding the rights issue of equity shares, clarifying the timeline for dispatch of issue materials. The company filed the corrigendum with stock exchanges on March 24, 2026, following its original advertisement published on March 23, 2026.

Rights Issue Overview

The rights issue involves the offering of up to 15,627,419 fully paid-up equity shares with a face value of ₹10 each. The company has set the issue price at ₹300.00 per rights equity share, which includes a premium of ₹290.00 per share. The offering follows a 1:2 ratio, meaning eligible equity shareholders will receive one rights equity share for every two fully paid-up equity shares held as on the record date of Tuesday, March 17, 2026.

Corrigendum Details

The corrigendum specifically addresses the section titled "Completion of Dispatch of Issue Material" in the original advertisement. The revised statement clarifies that the dispatch of the Application Form, Letter of Offer and Rights Entitlement Letter by email was completed on Wednesday, March 18, 2026, while the dispatch of physical copies of the Issue Material was completed on Friday, March 20, 2026.

Issue Timeline and Key Dates

The rights issue follows a structured timeline with specific dates for various activities. The issue will open on Friday, March 27, 2026, and close on Friday, April 10, 2026. Rights entitlements have already been credited to eligible shareholders' demat accounts on Wednesday, March 18, 2026, under the ISIN: INE618L20018.

Regulatory Compliance and Publication

The corrigendum has been published in multiple newspapers with wide circulation, including Financial Express (English national daily) - all editions, Jansatta (Hindi national daily) - all editions, and Navshakti (Marathi language daily) - Mumbai edition. The document is also available on the company's website at www.5paisa.com/investor-relations .

The company emphasized that the advertisement should be read in conjunction with this corrigendum, and all capitalized terms used in the corrigendum have the same meaning as ascribed in the Letter of Offer. MUFG Intime India Private Limited serves as the registrar to the issue, while the existing equity shares are listed on BSE Limited and National Stock Exchange of India Limited.

5paisa capital Limited has reached a settlement with the Securities and Exchange Board of India (SEBI) regarding its association with certain algorithmic trading platforms. The company disclosed the settlement under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, following a Settlement Order passed by the market regulator.

Settlement Details

SEBI has imposed a settlement amount of ₹1,00,000 on 5paisa Capital Limited under the Settlement Scheme for Association with Certain Algo Platforms, 2025. The order was dated March 17, 2026, and displayed on SEBI's website on March 18, 2026.

Nature of Violations

The settlement stems from SEBI's examination of Tradetron and other algorithmic trading platforms. During this investigation, certain stock-brokers were found to have their Application Programming Interfaces (APIs) integrated with such platforms. These platforms were observed to be displaying and marketing strategies that indicated assured or consistent returns to investors.

SEBI determined that such associations constituted alleged violations of:

• SEBI Circular dated September 02, 2022
• Provisions of the SEBI (Stock Brokers) Regulations, 1992

Financial Impact Assessment

5paisa Capital Limited has assessed that there is no material financial impact on the company beyond the payment of the settlement amount. The company has disclosed this information in compliance with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Compliance Framework Strengthening

Following the settlement, 5paisa Capital Limited has emphasized its commitment to strengthening its compliance framework. The company stated that it remains dedicated to adhering to all applicable regulatory requirements moving forward. This settlement allows the company to resolve the matter without admitting or denying the alleged violations while focusing on enhanced regulatory compliance.